{"id":"W3093890556","doi":"10.1016/j.lungcan.2020.10.008","title":"Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study","year":2020,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; Associazione Italiana per la Ricerca sul Cancro; MedImmune; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Eisai; Seattle Genetics; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Novartis; Ipsen; British Mycological Society; Daiichi-Sankyo; United Therapeutics Corporation; MSD Life Science Foundation, Public Interest Incorporated Foundation; Bayer; Celgene; AstraZeneca; Roche; Astellas Pharma US; Pfizer; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Oncology; Lung cancer; Clinical endpoint; Chemotherapy; Immunotherapy; Retrospective cohort study; Confidence interval; Gemcitabine; Hazard ratio; Cancer; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001516518,0.0004353257,0.0007697689,0.0005712631,0.0005257662,0.0009812228,0.0006306872,0.0009039376,0.001324864],"category_scores_gemma":[0.003526142,0.0005770103,0.001057794,0.001369386,0.0005217139,0.001125618,0.0008090933,0.0007011002,0.0002633676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008179149,"about_ca_system_score_gemma":0.000578262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005652603,"about_ca_topic_score_gemma":0.007874095,"domain_scores_codex":[0.9986953,0.0004371727,0.0001252974,0.0004027045,0.0001332746,0.0002063665],"domain_scores_gemma":[0.9968978,0.0005106294,0.001614463,0.0004272527,0.0002325322,0.0003172706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004160624,0.0001572212,0.9914705,0.00004298526,0.0005289624,0.0001363486,0.0001158083,0.0001067267,0.0006999953,0.00008584782,0.0003656914,0.002129238],"study_design_scores_gemma":[0.0002921758,0.00067355,0.997151,0.00001717583,0.0003671926,0.0002460109,0.0001903187,0.0001188952,0.0001055306,0.00003537835,0.0007904916,0.00001237754],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972816,0.001255483,0.000109358,0.00006772551,0.00001009073,0.00003220945,0.0007737108,0.000002774668,0.0004671445],"genre_scores_gemma":[0.9974694,0.0003938188,0.000102016,0.0001270568,0.00003968249,0.00002739608,0.001646902,0.000005880123,0.0001878793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005652603,"threshold_uncertainty_score":0.01123941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007440933025061391,"score_gpt":0.3071473753137865,"score_spread":0.2997064422887251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}